drugset / Trial / NCT00002399

A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients

NCT00002399 ↗

Phase 2 Completed 500 enrolled Schering-Plough
Double-blindTreatment

Summary

The purpose of this study is to compare the safety and effectiveness of SCH 56592 with that of fluconazole in the treatment of OPC (a fungal infection of the throat) in HIV-positive patients.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluconazole Small molecule — —
Subject Posaconazole Small molecule — —